Myeloid cells obtained from the blood but not from the tumor can suppress T-cell proliferation in patients with melanoma.
about
Depression and postoperative complications: an overviewThe Tumor Macroenvironment: Cancer-Promoting Networks Beyond Tumor BedsHampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancerMonitoring of the Immune Dysfunction in Cancer PatientsA Neoglycoconjugate Containing the Human Milk Sugar LNFPIII Drives Anti-Inflammatory Activation of Antigen Presenting Cells in a CD14 Dependent PathwayComputational algorithm-driven evaluation of monocytic myeloid-derived suppressor cell frequency for prediction of clinical outcomes.Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease.Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patientsCharacteristics of myeloid differentiation and maturation pathway derived from human hematopoietic stem cells exposed to different linear energy transfer radiation typesClinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanomaPresence of circulating Her2-reactive CD8 + T-cells is associated with lower frequencies of myeloid-derived suppressor cells and regulatory T cells, and better survival in older breast cancer patients.A simple and rapid protocol to non-enzymatically dissociate fresh human tissues for the analysis of infiltrating lymphocytes.A novel subset of B7-H3+CD14+HLA-DR-/low myeloid-derived suppressor cells are associated with progression of human NSCLC.Systemic Monocytic-MDSCs Are Generated from Monocytes and Correlate with Disease Progression in Breast Cancer PatientsPrognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohortCOX-2 promotes metastasis in nasopharyngeal carcinoma by mediating interactions between cancer cells and myeloid-derived suppressor cells.Effects of Immunonutrition for Cystectomy on Immune Response and Infection Rates: A Pilot Randomized Controlled Clinical TrialSTAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients.Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab.CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients.Identification of CD4(+)CD25(+)CD127(-) regulatory T cells and CD14(+)HLA(-)DR(-)/low myeloid-derived suppressor cells and their roles in the prognosis of breast cancerExploiting the curative potential of adoptive T-cell therapy for cancer.Inhibition of CSF-1 receptor improves the antitumor efficacy of adoptive cell transfer immunotherapy.PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors.Myeloid-derived suppressor cells in cancer: recent progress and prospects.Myeloid-derived suppressor cells in the inflammatory bowel diseases.Clinical significance of macrophage heterogeneity in human malignant tumors.Tumor-infiltrating lymphocyte therapy for melanoma: rationale and issues for further clinical development.Evolution of Our Understanding of Myeloid Regulatory Cells: From MDSCs to Mregs.MIF Is Necessary for Late-Stage Melanoma Patient MDSC Immune Suppression and Differentiation.CD11b+Ly6G+ cells inhibit tumor growth by suppressing IL-17 production at early stages of tumorigenesis.The immunobiology of myeloid-derived suppressor cells in cancer.Immune Recognition of the Epidemic Cystic Fibrosis Pathogen Burkholderia dolosa.Neutrophils dominate the immune cell composition in non-small cell lung cancerImmunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients.MIF inhibition reverts the gene expression profile of human melanoma cell line-induced MDSCs to normal monocytes.Myeloid-Derived Suppressor Cells in Cancers and Inflammatory Diseases: Angel or Demon?Enhanced suppressive capacity of tumor-infiltrating myeloid-derived suppressor cells compared with their peripheral counterparts.Untreated stage IV melanoma patients exhibit abnormal monocyte phenotypes and decreased functional capacity.Human Tumor-Infiltrating Myeloid Cells: Phenotypic and Functional Diversity.
P2860
Q26772908-B21FD079-1F1C-4558-8EFD-D454E4B1C27FQ26799120-F54F5F9D-0B9B-41DB-A9F1-A827F8168A14Q26863418-3B609C16-B964-478B-9DA5-D989CB3A02FDQ28072712-646CB768-CF56-4F1A-9F8A-5B7CFA289774Q28547758-4C85403E-2944-4300-BA12-6358FCA7F2E1Q34016867-F8F4C138-C4D8-4EBA-81CD-DEF50675897BQ34083483-09DE50D3-D4EF-4F12-9374-CE6782B0215AQ34250873-47A71476-D1E2-4FFE-8EF3-D0F5C7D3BBC6Q34649084-28EFB593-BD18-4473-93AB-613C1814B07FQ35078852-70E6BC7D-236A-4ABC-BDBA-74DD73695340Q35225664-4A841B80-459E-4968-BF82-D14C2DA7BDD6Q35415456-A6275112-3EBC-4337-B69C-21C01B7F8194Q35506243-47B19102-F204-4DF4-A50E-BE1F2B740F50Q35629271-B9C805F4-9093-4BF1-A12A-4C17DF162378Q36070763-100C311D-E4F2-4A3C-BA7A-448EB676FEC2Q36110362-B0E795C2-6B9B-4B9E-8103-F795068A8D36Q36691770-BBF63696-F32C-44A4-8FA1-B7FE414F0141Q36733391-58F6470C-ED3F-4166-93F6-7E41DA04AEBFQ36759111-42BADF60-65CD-4242-B912-180AD8001D5EQ36893225-30415795-D870-46B6-B10F-5ECDFBA202DAQ37108235-7E5636A5-24EC-4CCD-AF63-0DE50A99A866Q37576033-50431BB3-D8D7-42C5-93CC-FE148CB0DD0AQ37626265-C0F54152-5B53-46BA-B1BE-9005F98D2870Q37726682-FC54912C-C77B-47DA-807F-28915379712DQ38116711-8E933943-91D6-4334-A20A-886AC5D311B9Q38118052-DB1FC1BB-5815-49AC-AA57-66C1611D0A09Q38156195-31F0CFE9-B0F4-42C9-9226-98DD98B380ADQ38217028-72BACE87-B2C8-413B-A64E-5DF159FB9130Q38234941-EA7586F7-5FAE-4195-9A2D-8343B3F2CCAFQ38255030-EFF3A8F1-6620-4173-ADA6-5EFB9095F210Q38564280-BC7BCFDA-BBA1-48D0-BC2B-54AA43E0D6DCQ38649547-4B7CB46B-34F5-4330-993B-014C69FED74DQ38710198-A89B1835-D372-471A-A644-026192BE94D3Q38763346-3B7B2425-C91F-4EB1-8748-A4C2B48D0A6AQ38767735-D1A677EF-B3F7-4BA0-A964-E1DA7DD9F05EQ38783805-8D577D23-A178-4FD0-B082-1C3FFC9F5132Q38931895-B4BC2E13-09F9-4154-8DD8-BE9328CF7DDEQ39103952-23853FC8-A7A0-4360-B1C7-6AEDBBC9147CQ39142960-C50C0371-0B35-4B14-A4B1-E7519D1B3D0EQ39144794-2730A118-817A-40EF-840F-8D0D388C72E2
P2860
Myeloid cells obtained from the blood but not from the tumor can suppress T-cell proliferation in patients with melanoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Myeloid cells obtained from th ...... ion in patients with melanoma.
@en
Myeloid cells obtained from th ...... ion in patients with melanoma.
@nl
type
label
Myeloid cells obtained from th ...... ion in patients with melanoma.
@en
Myeloid cells obtained from th ...... ion in patients with melanoma.
@nl
prefLabel
Myeloid cells obtained from th ...... ion in patients with melanoma.
@en
Myeloid cells obtained from th ...... ion in patients with melanoma.
@nl
P2093
P1476
Myeloid cells obtained from th ...... tion in patients with melanoma
@en
P2093
John R Wunderlich
Mark E Dudley
Mojgan Ahmadzadeh
Simon Turcotte
Steven A Rosenberg
P304
P356
10.1158/1078-0432.CCR-12-1108
P407
P50
P577
2012-07-26T00:00:00Z